KLF9 and ovarian cancer: In ovarian cancer, the shift of KLF9 from pro-survival in primary tumors to tumor-suppressive in metastases involves microenvironmental stresses (hypoxia/3D mechanical stress) inducing conformational changes and reorganization of cofactor recruitment.